Nursing care
Why opioids cause constipation and why it does not wear off
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
Opioids bind mu receptors in the enteric nervous system as well as the brain. In the gut they suppress propulsive peristalsis and reduce fluid secretion, so stool moves slowly and dries out. Tolerance develops to pain relief and sedation but largely not to this colonic effect, so preventive bowel care should begin with the opioid.
How mu receptors in the gut slow stool
The bowel has its own nerve network, the enteric nervous system, and its neurons carry opioid receptors. When an opioid binds mu receptors there, it reduces release of acetylcholine and other signals that coordinate peristalsis. The waves that push stool forward weaken, while non-propulsive activity can persist, so contents churn without travelling.
Opioids also act on secretomotor neurons in the bowel wall. Less chloride is secreted into the lumen, so less water follows it. Because stool now stays longer in the colon, more water is absorbed as well. The combined result is hard, dry stool that is difficult to pass, with straining and a sense of incomplete emptying.
Why tolerance spares pain relief but not the colon
With repeated doses, many effects of opioids fade as receptors desensitise; this is tolerance. Research on enteric receptors suggests the colon behaves differently, with signalling that resists desensitisation. Tolerance has been shown in the small intestine but not in the colon. A patient may therefore need the same or higher doses for pain while constipation persists.
This explains a common exam trap. A distractor may claim the bowel will adjust after a few days, so laxatives can wait. The physiology points the other way: constipation is an expected, ongoing adverse effect for as long as the opioid continues. Planning for it is part of giving the medication safely, not an optional extra.
Translate the mechanism into assessment and prevention
Assess the baseline bowel pattern before the first dose and then each shift: date of last stool, consistency, straining, abdominal distension, discomfort, nausea and bowel sounds. Liquid stool leaking in a patient who has not had a formed stool for days can signal overflow around impaction rather than true diarrhoea, and it should be reported.
CDC guidance advises fluids, fibre and activity as tolerated, and notes that a stimulant laxative such as senna, with or without a softener, may be needed when opioids continue beyond a few days. A stool softener or fibre alone is discouraged because neither restores propulsion. Bulk fibre without adequate fluid can worsen hard stool, so check intake first.
Expected versus concerning bowel trends on opioids
Some slowing is expected once an opioid starts, so fewer and firmer stools are not surprising in themselves. What matters is the trend against the client's own baseline and whether the regimen is working. Clients who are older, immobile, dehydrated, recovering from surgery or receiving palliative care are particularly prone to severe constipation.
Concerning trends include several days without stool despite a scheduled regimen, increasing distension, cramping that worsens, nausea or vomiting, and loss of appetite. These suggest the regimen is inadequate or that impaction or obstruction is developing. Report them so the prescriber can review the plan rather than repeatedly offering the same as-needed laxative.
Work a hypothetical scenario
Imagine a hypothetical client on day three of scheduled oral opioids after hip surgery. They report no stool since admission, mild bloating and good pain control. Options are to request an order for a stool softener alone, encourage patience because tolerance will develop, or review the bowel regimen with the prescriber and add stimulant laxative therapy per protocol.
Reviewing the regimen is the strongest choice because the mechanism involves reduced propulsion that does not fade. Softener alone does not address motility, and waiting on tolerance misreads the physiology. If the abdomen became rigid, very distended or painful with vomiting, the priority would shift to escalating possible obstruction rather than giving more laxative.
Sources and further reading
Molecular physiology of enteric opioid receptors (PMC review). Mu receptor inhibition of enteric neurotransmission, reduced secretion, and lack of tolerance in the colon.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain, 2022 (MMWR). Constipation as a common opioid effect; fluids, fibre, activity and prophylactic stimulant laxative; avoid softener or fibre alone.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our basic care and comfort practice questions are the closest set to what this page covers.
One question from the basic care and comfort set
A nurse is preparing to feed a client who had a stroke and has mild dysphagia. Which action best reduces the risk of aspiration?
Rationale
Upright at 90 degrees with a chin tuck narrows the airway entrance and directs the bolus toward the esophagus — it is the single highest-yield positioning intervention for dysphagia. Thin liquids and straws move fastest and aspirate most easily, side-lying removes the gravity you want, and large bites overwhelm a swallow that is already impaired.
Answer: B
Common questions
Do clients become tolerant to opioid constipation over time?
Usually not to a useful degree. Tolerance develops to analgesia and sedation, but colonic opioid receptors resist desensitisation, so constipation tends to continue for as long as the opioid does.
Why is a stool softener alone often not enough?
A softener adds water to stool but does not restore the propulsive movement that opioids suppress. Guidance favours a stimulant laxative, with or without a softener, when opioids continue for more than a few days.
When should constipation in a client taking opioids be escalated?
Escalate severe abdominal pain, marked distension, vomiting, absent stool and flatus, or liquid leakage that suggests impaction, because these may indicate obstruction or impaction needing prompt medical review.